Keith C Ferdinand Selected Research

Hydrochlorothiazide (Esidrix)

11/2018	Comparison of Effectiveness of Azilsartan Medoxomil and Olmesartan in Blacks Versus Whites With Systemic Hypertension.
12/2013	Changes in Central Aortic Pressure, Endothelial Function and Biomarkers in Hypertensive African-Americans with the Cardiometabolic Syndrome: Comparison of Amlodipine/Olmesartan versus Hydrochlorothiazide/Losartan.
9/2013	Changes in biomarkers and 24 hours blood pressure in hypertensive African Americans with the metabolic syndrome: comparison of amlodipine/olmesartan versus hydrochlorothiazide/losartan.
9/2012	Vascular effects of nebivolol added to hydrochlorothiazide in African Americans with hypertension and echocardiographic evidence of diastolic dysfunction: the NASAA study.
5/2012	Aliskiren-based dual- and triple-combination therapies in high-risk US minority patients with stage 2 hypertension.
8/2011	Combination angiotensin-receptor blocker (ARB)/calcium channel blocker with HCTZ vs the maximal recommended dose of an ARB with HCTZ in patients with stage 2 hypertension: the exforge as compared to losartan treatment in stage 2 systolic hypertension (EXALT) study.
5/2011	Peripheral and central blood pressure responses of combination aliskiren/hydrochlorothiazide and amlodipine monotherapy in African American patients with stage 2 hypertension: the ATLAAST trial.
3/2011	Efficacy and safety of aliskiren-based dual and triple combination therapies in US minority patients with stage 2 hypertension.
4/2009	Irbesartan/hydrochlorothiazide for the treatment of isolated systolic hypertension: a subgroup analysis of the INCLUSIVE trial.
1/2008	Efficacy and safety of fixed combinations of irbesartan/hydrochlorothiazide in older vs younger patients with hypertension uncontrolled with monotherapy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Keith C Ferdinand Research Topics

Disease

50	Hypertension (High Blood Pressure) 01/2022 - 11/2003
20	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2003
15	Type 2 Diabetes Mellitus (MODY) 01/2021 - 10/2005
14	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2013 - 01/2003
11	Heart Failure 07/2016 - 08/2002
6	Coronary Disease (Coronary Heart Disease) 02/2011 - 05/2004
5	Stroke (Strokes) 02/2016 - 11/2003
5	Dyslipidemias (Dyslipidemia) 11/2015 - 12/2006
4	Hypercholesterolemia 06/2015 - 05/2004
3	COVID-19 12/2021 - 11/2020
3	Obesity 01/2019 - 10/2013
3	Myocardial Infarction 07/2011 - 11/2003
2	Diabetes Mellitus 01/2021 - 01/2006
2	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 09/2019 - 06/2015
2	Overweight 01/2019 - 01/2007
2	Body Weight (Weight, Body) 01/2019 - 08/2014
2	Coronary Artery Disease (Coronary Atherosclerosis) 08/2018 - 07/2015
2	Unstable Angina 02/2016 - 07/2011
2	Insulin Resistance 09/2013 - 07/2009
2	Proteinuria 06/2012 - 09/2005
2	Dizziness (Lightheadedness) 08/2011 - 04/2009
2	Isolated Systolic Hypertension 08/2011 - 04/2009
2	Atherosclerosis 04/2010 - 06/2004
2	Edema (Dropsy) 01/2008 - 09/2005
2	Prehypertension 01/2006 - 01/2006
1	Human Influenza (Influenza) 12/2020
1	Myocardial Ischemia (Ischemic Heart Diseases) 08/2018
1	Acute Coronary Syndrome 08/2018
1	Aortic Valve Disease 01/2018
1	Essential Hypertension 05/2017

Drug/Important Bio-Agent (IBA)

17	Antihypertensive Agents (Antihypertensives)IBA 01/2020 - 11/2003
15	LipidsIBA 11/2015 - 01/2003
14	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 11/2018 - 09/2005
10	CholesterolIBA 01/2016 - 05/2004
9	oxidized low density lipoproteinIBA 01/2021 - 09/2004
9	Amlodipine (Norvasc)FDA LinkGeneric 12/2013 - 11/2003
8	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 08/2002
8	LDL CholesterolIBA 09/2019 - 09/2004
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2015 - 09/2004
6	Angiotensin Receptor AntagonistsIBA 01/2021 - 01/2006
6	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2003
5	Biomarkers (Surrogate Marker)IBA 11/2020 - 11/2009
5	Pharmaceutical PreparationsIBA 01/2016 - 01/2003
5	HDL CholesterolIBA 11/2015 - 09/2004
5	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 10/2015 - 11/2003
5	Irbesartan FDA LinkGeneric 04/2009 - 10/2005
4	empagliflozinIBA 01/2020 - 01/2018
4	Losartan (Cozaar)FDA LinkGeneric 12/2013 - 11/2003
4	Rosuvastatin Calcium (Crestor)FDA Link 04/2012 - 09/2004
4	Triglycerides (Triacylglycerol)IBA 04/2012 - 09/2004
4	Isosorbide Dinitrate (Isordil)FDA LinkGeneric 02/2011 - 11/2005
4	Hydralazine (Apresoline)FDA LinkGeneric 02/2011 - 11/2005
3	DiureticsIBA 01/2022 - 11/2003
3	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019 - 08/2014
3	olmesartanIBA 11/2018 - 09/2013
3	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 10/2015 - 01/2006
3	Valsartan (Vals)FDA Link 10/2013 - 09/2005
3	Nebivolol FDA Link 09/2012 - 07/2009
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2012 - 07/2009
3	aliskiren FDA Link 05/2012 - 03/2011
2	ThiazidesIBA 01/2022 - 04/2013
2	VaccinesIBA 12/2021 - 12/2020
2	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021 - 05/2020
2	SodiumIBA 01/2020 - 01/2018
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2019 - 01/2018
2	Sodium-Glucose Transport ProteinsIBA 01/2019 - 08/2014
2	Chlorthalidone (Chlortalidone)FDA LinkGeneric 11/2018 - 11/2003
2	dulaglutideIBA 02/2016 - 10/2014
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 10/2014 - 08/2014
2	losartan drug combination hydrochlorothiazide FDA LinkGeneric 12/2013 - 09/2013
2	Valsartan Drug Combination Amlodipine FDA Link 10/2013 - 08/2011
2	C-Reactive ProteinIBA 07/2011 - 02/2011
2	atorvastatin drug combination amlodipine FDA Link 10/2009 - 01/2008
2	AntioxidantsIBA 07/2009 - 01/2008
2	Indicators and Reagents (Reagents)IBA 02/2006 - 01/2006
2	Pravastatin (Pravachol)FDA LinkGeneric 09/2004 - 06/2004
2	Atorvastatin (Lipitor)FDA Link 09/2004 - 06/2004
1	COVID-19 VaccinesIBA 01/2021
1	SolutionsIBA 01/2021
1	Ezetimibe (Zetia)FDA Link 09/2019
1	alirocumabIBA 09/2019
1	ReninIBA 01/2019
1	Glutamyl Aminopeptidase (Aspartyl Aminopeptidase)IBA 01/2019
1	SaltsIBA 01/2019
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2019
1	firibastatIBA 01/2019
1	azilsartan medoxomilIBA 11/2018
1	Hemoglobins (Hemoglobin)IBA 01/2018
1	Contraceptive Agents (Contraceptives)IBA 01/2018
1	Hormones (Hormone)IBA 01/2018
1	Biological ProductsIBA 01/2018
1	SymportersIBA 01/2018
1	Lipoprotein(a)IBA 01/2018
1	Type 3 Cyclic Nucleotide PhosphodiesterasesIBA 07/2016

Therapy/Procedure

32	Therapeutics 01/2022 - 08/2002
11	Drug Therapy (Chemotherapy) 01/2021 - 01/2006
2	Denervation 01/2021 - 01/2020
2	Secondary Prevention 11/2010 - 07/2009
1	Investigational Therapies (Experimental Therapy) 01/2020
1	Percutaneous Coronary Intervention 08/2018